Hormonal
Low-Glycemic Index (GI) diets promote greater weight loss, better insulin regulation, and lower weight regain compared to high-GI or conventional diets, primarily by enhancing satiety and minimizing postprandial insulin secretion.
Choose carbohydrates that digest slowly (low GI), such as vegetables, legumes, and whole grains, rather than refined grains and sugars. This helps control hunger and insulin levels, leading to better weight loss and maintenance.
diets based on low-GI foods may enhance weight control because they promote satiety, minimize postprandial insulin secretion, and maintain insulin sensitivity... patients who followed a low-GI diet during an 8-week energy-restricted period registered higher weight loss (7% of the initial body weight) than those included in a conventional diet (5% of the initial body weight)
Why this rating
The paper notes controversy and inconsistent results in longer-term studies, though short-term benefits are clear.
Source
Obesity and the metabolic syndrome: role of different dietary macronutrient distribution patterns and specific nutritional components on weight loss and maintenance
Itziar Abete et al. · Nutrition Reviews · 2010
DOI 10.1111/j.1753-4887.2010.00280.x
More from this paper
- Moderate-protein diets (30% energy) combined with carbohydrate restriction (40%) and fat restriction (30%) produce greater fat mass loss, better body composition, and higher long-term adherence compared to conventional high-carbohydrate diets (15% protein, 55% carbohydrates).Good
- Increased intake of omega-3 fatty acids (from fish or supplements) improves cardiometabolic health markers (blood pressure, triglycerides, inflammation, insulin sensitivity) in obese and metabolic syndrome patients, independent of weight loss.Good
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →